Invesco’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-408,807
| Closed | -$70.4M | – | 4161 |
|
|
2021
Q3 | $70.4M | Sell |
408,807
-52,609
| -11% | -$6.88M | 0.02% | 920 |
|
|
2021
Q2 | $57.9M | Sell |
461,416
-147,763
| -24% | -$18.6M | 0.01% | 1020 |
|
|
2021
Q1 | $82.6M | Buy |
609,179
+69,841
| +13% | +$9.02M | 0.02% | 881 |
|
|
2020
Q4 | $69M | Buy |
539,338
+201,673
| +60% | +$23.6M | 0.02% | 906 |
|
|
2020
Q3 | $38M | Buy |
337,665
+101,008
| +43% | +$10.1M | 0.01% | 1036 |
|
|
2020
Q2 | $22.5M | Buy |
236,657
+104,766
| +79% | +$10.1M | 0.01% | 1232 |
|
|
2020
Q1 | $11.9M | Buy |
131,891
+124,803
| +1,761% | +$9.7M | 0.01% | 1457 |
|
|
2019
Q4 | $376K | Sell |
7,088
-468
| -6% | -$21.3K | ﹤0.01% | 3357 |
|
|
2019
Q3 | $299K | Sell |
7,556
-296
| -4% | -$12.8K | ﹤0.01% | 3430 |
|
|
2019
Q2 | $323K | Sell |
7,852
-264
| -3% | -$10.9K | ﹤0.01% | 3478 |
|
|
2019
Q1 | $378K | Buy |
8,116
+1,711
| +27% | +$75.1K | ﹤0.01% | 3407 |
|
|
2018
Q4 | $279K | Buy |
6,405
+765
| +14% | +$38.2K | ﹤0.01% | 3474 |
|
|
2018
Q3 | $323K | Sell |
5,640
-42
| -0.7% | -$2.06K | ﹤0.01% | 3586 |
|
|
2018
Q2 | $276K | Buy |
5,682
+71
| +1% | +$2.59K | ﹤0.01% | 3620 |
|
|
2018
Q1 | $219K | Buy |
+5,611
| New | +$239K | ﹤0.01% | 3579 |
|
|
2016
Q4 | – | Sell |
-46,216
| Closed | -$1.67M | – | 3724 |
|
|
2016
Q3 | $1.67M | Buy |
+46,216
| New | +$1.53M | ﹤0.01% | 2648 |
|
|
2016
Q2 | – | Sell |
-31,967
| Closed | -$844K | – | 3743 |
|
|
2016
Q1 | $844K | Buy |
+31,967
| New | +$930K | ﹤0.01% | 3001 |
|
|
2015
Q3 | – | Sell |
-170
| Closed | -$5K | – | 4091 |
|
|
2015
Q2 | $5K | Buy |
+170
| New | +$5.49K | ﹤0.01% | 4243 |
|
|
2014
Q3 | – | Sell |
-283,027
| Closed | -$9.61M | – | 4128 |
|
|
2014
Q2 | $9.61M | Buy |
283,027
+41,527
| +17% | +$1.39M | ﹤0.01% | 1575 |
|
|
2014
Q1 | $8.33M | Buy |
241,500
+141,500
| +142% | +$6.39M | ﹤0.01% | 1615 |
|
|
2013
Q4 | $3.96M | Hold |
100,000
| – | – | ﹤0.01% | 2191 |
|
|
2013
Q3 | $2.22M | Buy |
+100,000
| New | +$2.16M | ﹤0.01% | 2473 |
|
Invesco's XLRN Position: Q4 2021 in Review
Invesco sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 408,807 shares — an estimated $70.4M sold.
Invesco first reported a position in XLRN in Q3 2013 and held it in 22 quarters. The position peaked at $82.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Invesco reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Invesco sold 408,807 Acceleron Pharma shares in Q4 2021, an estimated $70.4M.
- Invesco first reported a position in Acceleron Pharma in Q3 2013 and held it in 22 quarters.
- Invesco's Acceleron Pharma position peaked at $82.6M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.